...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What Monday Brings?

I have been sitting here wondering what if any good news we will hear. I know many are hoping that they are going forward with the IPO/company split. I can't see it happening until there is some reason to compel people to buy, not sell, this stock. I would think that KD would not be happy if the initial buy in on open market was less than $1.00 he just anteed up. And once people could trade this they would. Just to get some liquidity out of the rvx investment. So market gets flooded with Zenith shares and the price drops and KD would probably really not be pleased.

Share
New Message
Please login to post a reply